Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.
May 05, 2011
UCSF's basic research over nearly two decades has led to the first novel antitoxin to treat botulism in nearly a century – becoming the first recombinant human therapy to target one of the most dangerous substances known to man and offering a new defense against bioterrorism.
April 26, 2011
Scientists are making great strides in figuring out how the human brain develops, which are leading to novel ideas about the causes of a range of brain disorders, and are raising hopes for the regeneration of tissue that is lost in diseases such as Alzheimer’s.
April 15, 2011
San Francisco Mayor Edwin M. Lee toured San Francisco General Hospital, where UCSF physicians and allied health care professionals provide patient care services, including the City's only level one trauma center.
January 27, 2011
Five basic scientists at UCSF will be awarded the distinction of fellows by the American Association for the Advancement of Science (AAAS) on February 19.
January 05, 2011
Susan Hyde, an award-winning professor and scientist with the UCSF School of Dentistry, promotes practices that preserve oral health and quality of life for both patients and practitioners.
November 29, 2010
A UCSF research collaboration with GE Healthcare has produced the first results in humans of a new technology that promises to rapidly assess the presence and aggressiveness of prostate tumors in real time, by imaging the tumor’s metabolism.
November 19, 2010
UCSF’s Stanley Prusiner, who received the National Medal of Science from President Barack Obama on Wednesday, urges today’s students to become the next generation of scientists.
November 16, 2010
UCSF and Pfizer, Inc. have formed a new partnership to accelerate the translation of biomedical research into effective new medications and therapies for patients.
November 15, 2010
UCSF researchers have for the first time shown that an external optical pacemaker can be used in a vertebrate to control its heart rate.